<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Coleção:</title>
    <link>http://repositorio.ufc.br/handle/riufc/46776</link>
    <description />
    <pubDate>Sat, 13 Jun 2026 03:19:51 GMT</pubDate>
    <dc:date>2026-06-13T03:19:51Z</dc:date>
    <item>
      <title>Associações entre biomarcadores salivares inflamatórios e neurotróficos em crianças e adolescentes com Transtorno do Espectro Autista: estudo transversal em ambulatório de referência no Ceará</title>
      <link>http://repositorio.ufc.br/handle/riufc/85928</link>
      <description>Título: Associações entre biomarcadores salivares inflamatórios e neurotróficos em crianças e adolescentes com Transtorno do Espectro Autista: estudo transversal em ambulatório de referência no Ceará
Autor(es): Vianna, Marisa Perdigão de Negreiros
Abstract: Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental condition whose clinical complexity has driven the search for peripheral biomarkers capable of broadening the understanding of biological subgroups. In this context, saliva stands out as a promising matrix due to its non-invasive nature and good acceptability in pediatric populations. This study aimed to analyze the salivary profile of inflammatory cytokines (IL-1β, IL-6, and TNF-α) and neurotrophins (BDNF and β-NGF) in children and adolescents with ASD treated at a specialized outpatient clinic, as well as to investigate the associations among these biomarkers and their relationship with clinical and contextual variables. This was a translational, observational, analytical, cross-sectional study conducted with 69 participants aged 2 to 17 years. Salivary biomarkers were measured using immunoenzymatic assays, and statistical analysis included the Shapiro-Wilk test and Spearman’s correlation coefficient. All biomarkers showed non-normal distribution. In the total sample, a strong positive correlation was observed between IL-6 and TNF-α (ρ = 0.85; p &lt; 0.001), in addition to positive associations between both cytokines and β-NGF (ρ ≥ 0.71; p &lt; 0.001), configuring a more stable relational axis between inflammation and neurotrophic signaling. In age-stratified analyses, this pattern remained present, with greater cohesion in Group 1 (2–4 years) and maintenance of the associations among IL-6, TNF-α, and β-NGF in Group 2 (5–9 years) and Group 3 (10–17 years), whereas IL-1β and BDNF showed more variable behavior across strata. Exploratory associations were also identified between biomarkers and clinical and contextual variables, notably the negative correlation between BMI and β-NGF in Group 1, the positive correlation between family income and BDNF across different age groups, and the negative associations between food selectivity and IL-6/TNF-α in Group 3. It is concluded that salivary biomarkers revealed a consistent pattern of association between inflammation and neurotrophy, especially involving the IL-6, TNF-α, and β-NGF axis, reinforcing saliva as a promising matrix for translational research in ASD.
Tipo: Dissertação</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/85928</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Efeitos da azitromicina no sistema nervoso central em modelo de kindling induzido por pentilenotetrazol em camundongos</title>
      <link>http://repositorio.ufc.br/handle/riufc/85716</link>
      <description>Título: Efeitos da azitromicina no sistema nervoso central em modelo de kindling induzido por pentilenotetrazol em camundongos
Autor(es): Santiago, Rodrigo Maia
Abstract: Epilepsy is characterized by neuronal hyperexcitability and is associated with redox imbalance, which supports the investigation of drugs capable of modulating seizure outcomes and oxidative-nitrosative biomarkers. The effect of azithromycin (AZT) on the seizure phenotype and redox axis was evaluated in pentylenetetrazole (PTZ)-induced models in mice. An experimental, controlled, in vivo study was conducted, comprising an acute and a chronic model. In the acute model, AZT was administered intraperitoneally at doses of 100 or 200 mg/kg, followed by a challenge with 85 mg/kg PTZ to record the latencies to the first seizure and death. In the chronic model, PTZ-kindling (35 mg/kg on alternate days for 21 days) was used, with behavioral assessment using the Racine Scale. At the end of the protocols, reduced glutathione (GSH), nitrite, and thiobarbituric acid reactive substances (TBARS) were quantified in the prefrontal cortex, hippocampus, and striatum. A dual effect, dependent on dose and exposure time, was observed. In the acute model, AZT 100 mg/kg reduced the latency to the first seizure (median of 36 s vs. 49 s in the control), while AZT 200 mg/kg prolonged the time to death (median of 200 s vs. 173 s in the control). Biochemically, the acute phase was marked by a nitrosative peak, with a significant increase in nitrite across the three regions evaluated at the 200 mg/kg dose (p &lt; 0.01). In the chronic model, the 200 mg/kg dose transiently attenuated seizure severity (median score 3.0 vs. 4.0 in the control; p = 0.0407 on day 13), whereas the 100 mg/kg dose was associated with high mortality and the maintenance of high scores (median between 4.0 and 5.0). In contrast to the acute phase, no statistically significant changes were detected in the redox panel (p &gt; 0.05  for GSH, nitrite, and MDA) at the end of the kindling protocol, suggesting late biochemical adaptation or buffering. It was concluded that AZT acted as a complex and non-linear modulator in the central nervous system, with manifestations ranging from excitatory facilitation and transient behavioral attenuation to acute nitrosative induction, diverging from the profile of a classic and uniform neuroprotective agent.
Tipo: Dissertação</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/85716</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Mo-CBP3-PepIII altera o perfil proteômico de células de câncer gástrico, induz a formação de poros na membrana e o acúmulo excessivo de ROS</title>
      <link>http://repositorio.ufc.br/handle/riufc/85334</link>
      <description>Título: Mo-CBP3-PepIII altera o perfil proteômico de células de câncer gástrico, induz a formação de poros na membrana e o acúmulo excessivo de ROS
Autor(es): Oliveira, Talia Rabelo
Abstract: Plant-derived peptides have gained prominence due to the possibility of structural modifications and selective toxicity. Moringa oleifera gave rise to the peptide Mo-CBP3-PepIII, which was synthesized to achieve greater selectivity. Initially, it was investigated for its antimicrobial and antifungal activities; therefore, the promising results led to further analyses regarding its antitumor potential. In this study, its activity against gastric adenocarcinoma cells (AGS) was evaluated, demonstrating low toxicity toward normal gastric mucosal cells (MNP-01). The mechanism of action of the synthetic peptide was investigated. First, cytotoxicity analysis was performed to determine the IC₅₀ value, followed by the evaluation of membrane integrity, accumulation of reactive oxygen species, morphological alterations by scanning electron microscopy, and proteomic analysis. Proteomic profiling revealed that the peptide modulated proteins involved in proliferation, metabolism, cytoskeletal organization, stress response, cellular repair, and drug resistance. A reduction in the expression of pro-tumoral proteins essential for cancer development and survival was observed, while an increase in the abundance of some tumor suppressor proteins was detected. The peptide promoted increased cellular vulnerability to oxidative stress, an important mechanism in tumor cell lysis. Proteomic analysis highlighted a reduction in proteins highly associated with resistance to several therapies, such as CLIC1 and HNRNPC, whose downregulation is related to decreased resistance to cisplatin, oxaliplatin, and vincristine. Conversely, some proteins showed increased abundance, including TXNL1, which contributed to reduced resistance to cisplatin. These findings indicate a gastric antitumor effect with a multifaceted mechanism of action, involving increased membrane permeability, pore formation, and dysregulation of multiple intracellular pathways, suggesting that Mo-CBP3-PepIII is a promising therapeutic candidate, either alone or in combination with conventional drugs. Therefore, future studies should further elucidate its effects on apoptosis, migration, tumor invasion, and associated signaling pathways, as well as deepen the investigation of the proteins identified in this study to better understand their roles in tumor biology and the potential interaction of Mo-CBP3-PepIII with conventional chemotherapeutic agents.
Tipo: Dissertação</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/85334</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Análise do perfil ultraestrutural e molecular das linhagens MNP-01 e AGP-01: identificação de biomarcadores associados ao fenótipo maligno no câncer gástrico</title>
      <link>http://repositorio.ufc.br/handle/riufc/85125</link>
      <description>Título: Análise do perfil ultraestrutural e molecular das linhagens MNP-01 e AGP-01: identificação de biomarcadores associados ao fenótipo maligno no câncer gástrico
Autor(es): Vieira, Antônia Catarine Gomes
Abstract: Gastric cancer (GC) is a global public health challenge, ranking fifth in both incidence and mortality among malignant neoplasms. Its development is multifactorial, involving genetic, epigenetic, biochemical, and morphological alterations. Considering the scarcity of studies in Brazilian populations, this study aimed to compare the ultrastructural and molecular profiles of the gastric cell lines MNP-01 (non-tumoral) and AGP-01 (tumoral), in order to prospect protein biomarkers associated with the malignant phenotype. Ultrastructural and nanomechanical parameters were evaluated by AFM, while protein and other biomolecule profiles were analyzed by shotgun proteomics (UHPLC-MS/MS) and Raman spectroscopy, respectively. AFM maps revealed differences in the cell surface: the tumor cell line AGP-01 exhibited lower roughness, tumor volume, and surface area, as well as greater deformability and reduced Young’s modulus and adhesion values. In turn, Raman spectroscopy revealed differences in the vibrational profile as well as a distinct molecular composition, including nucleic acids, lipids, and proteins. Proteomics identified 2,209 proteins, of which 433 were exclusive to the MNP-01 lineage, 328 to the AGP-01 lineage, and 724 shared between both. From this total, proteins involved in protein synthesis and translation, oxidative stress and metabolism, cell cycle regulation, cell adhesion, drug resistance, and cytoskeletal reorganization were highlighted. Protein interaction and functional analyses indicated alterations in oncogenic pathways, especially AKT/mTOR, which were confirmed by immunofluorescence. The tumoral lineage AGP-01 showed a significant increase in p-AKT (1.8× vs. MNP-01; p = 0.0289) and p-mTOR (3× vs. MNP-01; p = 0.004), indicating hyperactivation of this pathway as a feature of the malignant phenotype. Altogether, the results demonstrate that the AGP-01 tumor cell line is associated with the integration of ultrastructural alterations, proteomic reprogramming, and activation of pro-survival pathways, broadening the understanding of tumor biology and the biomechanical and molecular bases of metastatic GC, providing support for the identification and investigation of potential therapeutic targets, as well as for future studies with functional validation and translational application.
Tipo: Dissertação</description>
      <pubDate>Thu, 01 Jan 2026 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://repositorio.ufc.br/handle/riufc/85125</guid>
      <dc:date>2026-01-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

